Rockefeller Capital Management’s Clough Global Dividend & Income Fund GLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.7K Hold
4,174
﹤0.01% 3618
2025
Q4
$24.9K Sell
4,174
-3,209
-43% -$19.3K ﹤0.01% 3411
2025
Q3
$43.9K Buy
+7,383
New +$42.4K ﹤0.01% 2975
2023
Q1
Sell
-1,018
Closed -$6K 2749
2022
Q4
$6K Sell
1,018
-19,408
-95% -$133K ﹤0.01% 3271
2022
Q3
$135K Sell
20,426
-12,297
-38% -$98.4K ﹤0.01% 1832
2022
Q2
$266K Buy
32,723
+4,997
+18% +$43.6K ﹤0.01% 1513
2022
Q1
$255K Hold
27,726
﹤0.01% 1591
2021
Q4
$297K Buy
27,726
+2,581
+10% +$28.7K ﹤0.01% 1507
2021
Q3
$278K Buy
25,145
+14,618
+139% +$168K ﹤0.01% 1476
2021
Q2
$114K Buy
+10,527
New +$122K ﹤0.01% 1738

Other funds holding GLV

Rockefeller Capital Management's GLV Position: Q1 2026 in Review

Rockefeller Capital Management held its Clough Global Dividend & Income Fund (GLV) position steady in Q1 2026 at 4,174 shares worth $24.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3618.

Rockefeller Capital Management first reported a position in GLV in Q2 2021 and has held it in 10 quarters since. The position peaked at $297K in Q4 2021. 41 funds tracked by Wall St. Rank hold GLV as of Q1 2026.

  • Rockefeller Capital Management held 4,174 shares of Clough Global Dividend & Income Fund worth $24.7K as of Q1 2026.
  • Rockefeller Capital Management left its Clough Global Dividend & Income Fund share count unchanged in Q1 2026.
  • Clough Global Dividend & Income Fund made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #3618 holding.
  • Rockefeller Capital Management first reported a position in Clough Global Dividend & Income Fund in Q2 2021 and has held it in 10 quarters since.
  • Rockefeller Capital Management's Clough Global Dividend & Income Fund position peaked at $297K in Q4 2021.
  • 41 funds tracked by Wall St. Rank held Clough Global Dividend & Income Fund as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.